Showing results by author "Katie Thomas" in All Categories
-
-
Disease Experts Issue Warnings That Vaccine for Virus May Be Years Away
- Written by: Katie Thomas
- Narrated by: Kristi Burns
- Length: 5 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"Disease Experts Issue Warnings That Vaccine for Virus May Be Years Away" is from the World section of The New York Times. It was written by Katie Thomas and narrated by Kristi Burns.
Preview -
Disease Experts Issue Warnings That Vaccine for Virus May Be Years Away
- Narrated by: Kristi Burns
- Length: 5 mins
- Release Date: 31-01-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹165.26 or free with 30-day trial
-
-
-
Race to Find Zika Vaccine Tests Limits of Biotech
- Written by: Katie Thomas
- Narrated by: Fleet Cooper
- Length: 8 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"Race to Find Zika Vaccine Tests Limits of Biotech" is from the November 18, 2016 Business section of The New York Times. It was written by Katie Thomas and narrated by Fleet Cooper.
Preview -
Race to Find Zika Vaccine Tests Limits of Biotech
- Narrated by: Fleet Cooper
- Length: 8 mins
- Release Date: 21-11-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
-
20 States Accuse Generic Drug Companies of Price Fixing
- Written by: Katie Thomas
- Narrated by: Kristi Burns
- Length: 5 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"20 States Accuse Generic Drug Companies of Price Fixing" is from the December 15, 2016 Business section of The New York Times. It was written by Katie Thomas and narrated by Kristi Burns.
Preview -
20 States Accuse Generic Drug Companies of Price Fixing
- Narrated by: Kristi Burns
- Length: 5 mins
- Release Date: 16-12-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
-
Kidney Fund Seen Insisting on Donations, Contrary to Government Deal
- Written by: Katie Thomas, Reed Abelson
- Narrated by: Kristi Burns
- Length: 8 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"Kidney Fund Seen Insisting on Donations, Contrary to Government Deal" is from the December 25, 2016 Business section of The New York Times. It was written by Katie Thomas and Reed Abelson and narrated by Kristi Burns.
Preview -
Kidney Fund Seen Insisting on Donations, Contrary to Government Deal
- Narrated by: Kristi Burns
- Length: 8 mins
- Release Date: 26-12-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
-
An EpiPen Rival Is about to Return to the Shelves
- Written by: Katie Thomas
- Narrated by: Kristi Burns
- Length: 5 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"An EpiPen Rival Is about to Return to the Shelves" is from the October 26, 2016 Business section of The New York Times. It was written by Katie Thomas and narrated by Kristi Burns.
Preview -
An EpiPen Rival Is about to Return to the Shelves
- Narrated by: Kristi Burns
- Length: 5 mins
- Release Date: 27-10-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
-
Mylan Chief's Answers on EpiPen Frustrate House Panel
- Written by: Katie Thomas
- Narrated by: Kristi Burns
- Length: 6 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"Mylan Chief's Answers on EpiPen Frustrate House Panel" is from the September 21, 2016 Business section of The New York Times. It was written by Katie Thomas and narrated by Kristi Burns.
Preview -
Mylan Chief's Answers on EpiPen Frustrate House Panel
- Narrated by: Kristi Burns
- Length: 6 mins
- Release Date: 22-09-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
-
Valeant Seeks New Chief Executive and Puts Ackman on Board
- Written by: Katie Thomas
- Narrated by: Fleet Cooper
- Length: 6 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
"Valeant Seeks New Chief Executive and Puts Ackman on Board" is from March 21, 2016, Business section of The New York Times. It was written by Katie Thomas and narrated by Fleet Cooper.
Preview -
Valeant Seeks New Chief Executive and Puts Ackman on Board
- Narrated by: Fleet Cooper
- Length: 6 mins
- Release Date: 22-03-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
-
Hefty Price Set on a New Drug that can Stunt Muscle Disease
- Written by: Katie Thomas
- Narrated by: Mike DelGaudio
- Length: 6 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
The Food and Drug Administration has approved the first drug to treat patients with spinal muscular atrophy, a savage disease that, in its most severe form, kills infants before they turn 2.
"Hefty Price Set on a New Drug that can Stunt Muscle Disease" is from the December 30, 2016 Financial section of The New York Times. It was written by Katie Thomas and narrated by Mike DelGaudio.
Preview -
Hefty Price Set on a New Drug that can Stunt Muscle Disease
- Narrated by: Mike DelGaudio
- Length: 6 mins
- Release Date: 01-01-17
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹152.09 or free with 30-day trial
-
-
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-
-
Dr. Katie
- Written by: Dr. Katie Thomas
- Original Recording
-
Overall0
-
Performance0
-
Story0
The Dr. Katie Show Podcast empowers aspiring millennial executives with helpful and hilarious interviews featuring industry leaders and change-makers. Each episode offers relatable stories and practical strategies that redefine success and promote career growth in the corporate world. Our goal is to inspire, support, and entertain listeners as they advance their leadership journey.
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-
-